Next year, more than 100 of the burrito chain’s new locations will use all-electric equipment and some additional elements from the new design.

Dr. Robert Califf says in an interview with CNBC that better regulation is needed to combat health misinformation that’s costing Americans years of life.

The firm sees an upside of almost 14% for the stock.

Moderna said on Tuesday it had not enrolled enough cases in a late-stage trial of its experimental flu vaccine to determine if the shot was successful or not.

Inflation, economy-wide instability and rising interest rates are putting stress on U.S. adults.

The firm said the company could be challenged by cooling originations and steepening losses on held-for-investment loans.

With inflation stubbornly high, more than half of all Americans are living paycheck to paycheck, according to a new report.

The intelligence leaks have brought forth new controversial information about adversaries and allies alike.

Analyst Susan Maklari upgraded the stock to buy from neutral. Maklari’s price target of $160 implies the stock could rally 24% over the next 12 months.

The Cyberspace Administration of China’s draft rules on generative AI come after tech giants Alibaba and Baidu launched their own ChatGPT-style products.